צמיחת רווח נקי למניה משנה לשנה ב-12 החודשים האחרונים Koninklijke Philips NV (PHG)

The stability of Koninklijke Philips N.V. (PHG) is confirmed by the transparency of lawsuit payouts and the restoration of management's reputation. The quarterly EPS evolution clearly demonstrates this trend, where -85.70 becomes the new value of the indicator. The business relies on the defensive profile of medtech with low cyclicality, although strict regulatory oversight and the consequences of ventilator recalls create certain pressure on financial dynamics.
פילוחים אנליטיים ודוחות נתונים של חברת Koninklijke Philips N.V. (PHG)

The innovative status of Koninklijke Philips N.V. (PHG) in the medtech sector requires colossal R&D expenditures and regular structural reforms. This metric measures the dynamics of net earnings per share, reflecting the actual efficiency of intellectual capital monetization. It is critical for investors to track the stability of this growth to assess liquidity generation rates. Sharp fluctuations signal risks of capital freezing. By analyzing the quarterly change in earnings per share, one can determine the resilience of the business model.